CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,814,539 | +50.8% | 538,319 | +85.9% | 0.03% | +57.9% |
| Q2 2023 | $9,823,515 | -18.2% | 289,523 | -13.2% | 0.02% | -26.9% |
| Q1 2023 | $12,005,303 | -59.6% | 333,666 | -50.0% | 0.03% | -61.2% |
| Q4 2022 | $29,717,003 | +62.0% | 666,749 | +2.1% | 0.07% | +67.5% |
| Q3 2022 | $18,348,000 | +3304.1% | 652,721 | +3159.9% | 0.04% | +3900.0% |
| Q2 2022 | $539,000 | +27.4% | 20,023 | -2.7% | 0.00% | -50.0% |
| Q1 2021 | $423,000 | +100.5% | 20,580 | +71.2% | 0.00% | +100.0% |
| Q4 2020 | $211,000 | – | 12,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |